Recent news and posts
Opportunity to apply for Joint Scientific Consultations within EU HTAR framework now open
On June 2, 2025, the submission period for Joint Scientific Consultations (JSCs) requests under the EU Health Technology Assessment Regulation (HTAR) framework opened. This marks the second submission window opened by the European Commission for JSCs under the HTAR. While the first call was limited to medicines, the current call is open to medical devices as well.
JSCs allow developers to consult on study planning for their products, focusing on the data and evidence needed for an eventual Joint Clinical Assessment (JCA). This process is intended to support more efficient evidence generation and improve the overall quality of submissions.
Developers of medical devices and medicines can now apply for the following planned JSC time slots:
- 29 September–2 October 2025 (Briefing document by September 01, 2025);
- 27–30 October 2025 (Briefing document by September 29, 2025);
- 24–27 November 2025 (Briefing document by October 27, 2025);
- 12–15 January 2026 (Briefing document by December 1, 2025).
JSC requests must be submitted via the HTA IT Platform by June 30, 2025. Templates for medical device submissions are available here. Briefing document is a more comprehensive dossier submitted after JSC request was approved. The briefing document is a more detailed dossier submitted after a JSC request has been approved. Templates for medical devices and in vitro diagnostics (IVDs) can be accessed here.
The full details can be found here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.